Ashland Stock To Go Ex-dividend Tomorrow (ASH)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- The ex-dividend date for Ashland (NYSE: ASH) is tomorrow, November 29, 2012. Owners of shares as of market close today will be eligible for a dividend of 23 cents per share. At a price of $70.10 as of 9:30 a.m. ET, the dividend yield is 1.3%.

The average volume for Ashland has been 795,400 shares per day over the past 30 days. Ashland has a market cap of $5.45 billion and is part of the basic materials sector and chemicals industry. Shares are up 22.2% year to date as of the close of trading on Tuesday.

Ashland Inc. operates as a specialty chemicals company in the United States and internationally. It operates through four segments: Specialty Ingredients, Water Technologies, Performance Materials, and Consumer Markets. The company has a P/E ratio of 144.1, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Ashland as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, solid stock price performance, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Ashland Ratings Report.

See our dividend calendar or top-yielding stocks list.

FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.
null

If you liked this article you might like

'Mad Money' Lightning Round: Southwestern Energy, UnitedHealth, Celgene and More

Jim Cramer's 'Mad Money' Recap: Don't Worry About a Little Market Detour

2 Specialty Chemical Stocks With Breakout Potential

3 Stocks Improving Performance Of The Chemicals Industry

Analysts' Actions -- Activision, Garmin, Match, Sirius and More